NC
IBB icon

NewSquare Capital’s iShares Biotechnology ETF IBB Stock Holding History

NewSquare Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20
Closed -$2.54K – 726
2023
Q2 		$2.54K Hold
20
– – ﹤0.01% 497
2023
Q1 		$2.58K Hold
20
– – ﹤0.01% 544
2022
Q4 		$2.63K Buy
+20
New +$2.58K ﹤0.01% 451

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NewSquare Capital's IBB Position: Q3 2023 in Review

NewSquare Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 20 shares — an estimated $2.54K sold.

NewSquare Capital first reported a position in IBB in Q4 2022 and held it in 3 quarters. The position peaked at $2.63K in Q4 2022. 832 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

  • NewSquare Capital reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
  • NewSquare Capital sold 20 iShares Biotechnology ETF shares in Q3 2023, an estimated $2.54K.
  • NewSquare Capital first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 3 quarters.
  • NewSquare Capital's iShares Biotechnology ETF position peaked at $2.63K in Q4 2022.
  • 832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.